Clinical Endocannabinoid Deficiency Reconsidered posted on February 18, 2020 Clinical Endocannabinoid Deficiency Reconsidered: Current Research Supports the Theory in Migraine, Fibromyalgia, Irritable Bowel, and Other Treatment-Resistant SyndromesEthan B. RussoPublished in Cannabis and Cannabinoid Research Clinical Endocannabinoid Deficiency Reconsidered 1 file(s) 526 KB Download